Flubromazolam (JYI-73) is a benzodiazepine derivative. Flubromazolam is reputed to be highly potent, and concerns have been raised that clonazolam and flubromazolam in particular may pose comparatively higher risks than other designer benzodiazepines, du

N-Desalkylflurazepam (also known as norflurazepam) is a benzodiazepine and an active metabolite of several other benzodiazepine drugs including flurazepam, flutoprazepam,fludiazepam, flutazolam,. It is long-acting, prone to accumulation, and binds unsel

Pyrazolam (SH-I-04)is a benzodiazepine derivative originally developed by a team led by Leo Sternbach at Hoffman-La Roche in the 1970s, and subsequently "rediscovered" and sold as a designer drug starting in 2012. Pyrazolam has structural similarities t

Etizolam is a thienodiazepine which is chemically related to benzodiazepine (BDZ) drug class; it differs from BDZs in having a benzene ring replaced with a thiophene ring. It is an agonist at GABA-A receptors and possesses amnesic, anxiolytic, anticonvuls

BROMAZOLAM is a benzodiazepine derivative. It possesses anxiolytic, anticonvulsant, sedative, and antidepressant properties, it was never FDA approved and was never available to the public. This product is intended for laboratory research purposes only

3-HYDROXYPHENAZEPAM is a benzodiazepine with hypnotic, sedative, anxiolytic, and anticonvulsant properties, Relative to phenazepam, 3-hydroxyphenazepam has diminished myorelaxant properties, but is about equivalent in most other regards.Like other benzodi